| DNA melting analysis for detection of single nucleotide polymorphisms RH Lipsky, CM Mazzanti, JG Rudolph, K Xu, G Vyas, D Bozak, MQ Radel, ... Clinical chemistry 47 (4), 635-644, 2001 | 155 | 2001 |
| Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms DL Kelly, KM Sullivan, JP McEvoy, RP McMahon, HJ Wehring, JM Gold, ... Journal of clinical psychopharmacology 35 (4), 374-381, 2015 | 104 | 2015 |
| A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies J Jackson, W Eaton, N Cascella, A Fasano, D Warfel, S Feldman, ... Schizophrenia research 140, 262, 2012 | 77 | 2012 |
| Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms. DL Kelly, G Vyas, CM Richardson, M Koola, RP McMahon, RW Buchanan, ... Schizophrenia research 133 (1-3), 257-258, 2011 | 54 | 2011 |
| Clozapine in reducing aggression and violence in forensic populations K Patchan, G Vyas, AL Hackman, M Mackowick, CM Richardson, ... Psychiatric quarterly 89, 157-168, 2018 | 44 | 2018 |
| The risk of suicide after clozapine discontinuation: Cause for concern KM Patchan, C Richardson, G Vyas, DL Kelly Annals of clinical psychiatry: official journal of the American Academy of …, 2015 | 42 | 2015 |
| Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study DL Kelly, HK Demyanovich, KM Rodriguez, D Čiháková, MV Talor, ... Journal of Psychiatry and Neuroscience 44 (4), 269-276, 2019 | 36 | 2019 |
| Blood draw barriers for treatment with clozapine and development of a point-of-care monitoring device DL Kelly, H Ben-Yoav, GF Payne, TE Winkler, SE Chocron, E Kim, ... Clinical Schizophrenia & Related Psychoses 12 (1), 23-30, 2018 | 35 | 2018 |
| Current status of clozapine in the United States DL Kelly, HJ Wehring, G Vyas Shanghai Archives of Psychiatry 24 (2), 110, 2012 | 30 | 2012 |
| Adjunct aripiprazole reduces prolactin and prolactin-related adverse effects in premenopausal women with psychosis: results from the DAAMSEL clinical trial DL Kelly, MM Powell, HJ Wehring, MKA Sayer, AM Kearns, AL Hackman, ... Journal of clinical psychopharmacology 38 (4), 317-326, 2018 | 29 | 2018 |
| Adjunctive minocycline in clozapine-treated patients with schizophrenia: analyzing the effects of minocycline on clozapine plasma levels HJ Wehring, T Elsobky, JP McEvoy, G Vyas, CM Richardson, ... Psychiatric Quarterly 89, 73-80, 2018 | 23 | 2018 |
| Evaluation of the safety of clozapine use in patients with benign neutropenia CM Richardson, EA Davis, GR Vyas, BA DiPaula, RP McMahon, DL Kelly The Journal of clinical psychiatry 77 (11), 3081, 2016 | 15 | 2016 |
| Comparison of novel immunoassay with liquid chromatography/tandem mass spectrometry (LC-MS/MS) for therapeutic drug monitoring of clozapine T Buckley, C Kitchen, G Vyas, NA Siegfried, E Tefera, S Chen, BA DiPaula, ... Therapeutic Drug Monitoring 42 (5), 771-777, 2020 | 13 | 2020 |
| Prebiotic treatment increases serum butyrate in people with schizophrenia: results of an open-label inpatient pilot clinical trial DL Kelly, MA Kane, CM Fraser, MKA Sayer, S Grant-Beurmann, T Liu, ... Journal of Clinical Psychopharmacology 41 (2), 200-202, 2021 | 6 | 2021 |
| Development of a lab-on-a-chip biosensor for clozapine monitoring DL Kelly, H Ben-Yoav, V Stock, T Winkler, G Payne, S Chocron, E Kim, ... Neuropsychopharmacology 38, S237-S238, 2013 | 6 | 2013 |
| The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G CR Friendshuh, A Pocivavsek, H Demyonovich, KM Rodriguez, ... Journal of clinical psychopharmacology 40 (3), 317-319, 2020 | 5 | 2020 |
| 120. Benign Ethnic Neutropenia in a Sample of Nigerian Healthy Controls and Clozapine-Treated Schizophrenia Patients With DARC Null Variant I Wonodi, T Oduguwa, I Amoo, A Adebayo, T Adebimpe, O Kalejaiye, ... Schizophrenia bulletin 43 (suppl_1), S67-S67, 2017 | 5 | 2017 |
| A new blood-based diagnostic aid for schizophrenia DL Kelly, S Thedford, G Vyas Psychiatric Services 62 (9), 1107-1107, 2011 | 5 | 2011 |
| Clozapine and neutrophil response in patients of African descent: a six-month, multinational, prospective, open-label clinical trial DL Kelly, M Glassman, I Wonodi, G Vyas, CM Richardson, E Nwulia, ... Schizophrenia Research 268, 312-322, 2024 | 4 | 2024 |
| Undiagnosed Lyme disease in adults with schizophrenia MM Koola, KM Sullivan, AK Earl, SM Feldman, C Richardson, GR Vyas, ... Schizophrenia research 168 (1-2), 579, 2015 | 4 | 2015 |
